FibroBiologics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| GARCIA RUBEN A | General Counsel | Purchase | 140,000 | $0.34 | $47,600 | 140,000 | Dec 11, 2025 |
| Khoja Hamid | Chief Scientific Officer | Purchase | 20,000 | $0.84 | $16,800 | 31,250 | May 27, 2025 |
| O'HEERON PETE | Chief Executive Officer | Gift | 100,000 | — | — | 5,906,647 | Dec 9, 2024 |
| O'HEERON PETE | Chief Executive Officer | Gift | 50,000 | — | — | 6,006,647 | Dec 3, 2024 |
| O'HEERON PETE | Chief Executive Officer | Purchase | 8,500 | $1.91 | $16,235 | 6,056,647 | Aug 12, 2024 |
| Khoja Hamid | Chief Scientific Officer | Purchase | 10,000 | $1.90 | $19,000 | 11,250 | Aug 12, 2024 |